Organization: Health Canada
Year: 2023
Month: October
Request Number: A-2023-000301
Request Summary: The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Clinical Practice (GCP) inspection of the Merck Canada facility in Kirkland, Quebec, for the Region of Alberta starting around 25 May 2021. Reference Number 182348.
Disposition: Disclosed in part
Number of pages: 10